ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀÇ 2023³â ½ÃÀå ±Ô¸ð´Â 512¾ï 4,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³â¿¡´Â 579¾ï 6,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2030³â¿¡´Â CAGR 13.30%·Î ¼ºÀåÇÏ¿© 1,228¾ï 9,000¸¸ ´Þ·¯·Î µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ȯÀÚ°¨½ÃÀåºñÀÇ ´ë»ó¹üÀ§¿¡´Â º´¿ø, Ŭ¸®´Ð, °¡Á¤ µî ´Ù¾çÇÑ ÇコÄɾî ȯ°æ¿¡¼ ½É¹Ú¼ö, Ç÷¾Ð, »ê¼ÒÆ÷ȵµ, È£Èí¼ö µîÀÇ Áß¿äÇÑ °Ç° ÆĶó¹ÌÅ͸¦ ÃßÀûÇϴµ¥ »ç¿ëµÇ´Â µµ±¸³ª ±â¼úÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ Àåºñ´Â Áö¼ÓÀûÀÎ °Ç° ¸ð´ÏÅ͸µ, Àû½Ã ÀÇ·á °³ÀÔ, ¸¸¼º Áúȯ °ü¸®, ¼ö¼ú ÈÄ °ü¸®, Áß¿äÇÑ Ä¡·á ½Ã³ª¸®¿À¿¡¼ ȯÀÚ °á°ú °³¼±¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÀÇ·á ¼¾ÅÍ, ÀçÅÃÄ¡·á µîÀ̸ç, ´Ù¾çÇÑ Çコ Äɾî ȯ°æ¿¡¼ÀÇ ¿ëµµÀÇ ³ÐÀÌ°¡ ÇÏÀ̶óÀÌÆ®°¡ µÇ°í ÀÖ½À´Ï´Ù. °°Àº ±Þ¼ÓÇÑ ±â¼ú ¹ßÀüÀÇ ¿µÇâ ¶ÇÇÑ COVID-19 ¹× COVID-19 ÀÌÈÄ ¿ø°Ý ¹× ¹«¼± ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ¿ø°Ý ÀÇ·á È®ÀåÀÇ °¡´É¼ºÀ» °Á¶ÇÏ°í ½ÇÁúÀûÀÎ ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù.
ÁÖ¿ä ½ÃÀå Åë°è |
±âÁسâ(2023) |
512¾ï 4,000¸¸ ´Þ·¯ |
¿¹Ãø³â(2024) |
579¾ï 6,000¸¸ ´Þ·¯ |
¿¹Ãø³â(2030) |
1,228¾ï 9,000¸¸ ´Þ·¯ |
CAGR(%) |
13.30% |
ÀÌ·¯ÇÑ ÀáÀç·ÂÀ» È°¿ëÇÏ·Á¸é °Ç° °ü¸® ¼Ö·ç¼Ç Á¦°ø¾÷ü°¡ AI¸¦ È°¿ëÇÑ ¿ø°Ý ¸ð´ÏÅ͸µ ±â¼ú¿¡ ÅõÀÚÇÏ¿© µ¥ÀÌÅÍÀÇ Á¤È®¼ºÀ» ³ôÀÌ°í ȯÀÚÀÇ Àû±ØÀûÀÎ Ä¡·á¸¦ À§ÇÑ ¿¹Ãø ºÐ¼®À» °¡´ÉÇÏ°Ô ÇÏ´Â °ÍÀÌ ¹Ù¶÷Á÷ÇÕ´Ï´Ù. ¶ÇÇÑ »óÈ£ ¿î¿ë¼º°ú ±âÁ¸ EMR ½Ã½ºÅÛ °£ÀÇ ÅëÇÕ¿¡ ÁßÁ¡À» µÐ Çõ½Åµµ »õ·Î¿î ±âȸ¸¦ À̲ø¾î ³¾ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª Ãʱ⠺ñ¿ëÀÇ ³ôÀÌ, ±ÔÁ¦»óÀÇ Àå¾Ö¹°, µ¥ÀÌÅÍ º¸¾È ¹× ȯÀÚÀÇ ÇÁ¶óÀ̹ö½Ã¿¡ ´ëÇÑ ¿ì·Á µîÀ¸·Î ÀÎÇØ ½ÃÀå ¼ºÀåÀº ÇÑ°è¿¡ Á÷¸é ÇØ ÀÖ½À´Ï´Ù. ½ÃÀå µµÀÔ¿¡´Â ÇʼöÀûÀÔ´Ï´Ù. ¶ÇÇÑ ¼¾¼ ±â¼ú°ú ºñħ½ÀÀû ¸ð´ÏÅ͸µ ¿¬±¸°¡ ÁøÇàµÇ¸é Å« Áøº¸·Î À̾îÁú ¼ö ÀÖ½À´Ï´Ù.
°úÁ¦´Â ÀÖ´õ¶óµµ ½ÃÀåÀÇ Çõ½ÅÀûÀÎ ÇÁ·ÐƼ¾î´Â »ç¿ëÀÚ Ä£ÈÀûÀÌ°í ½Ç½Ã°£ ¿¬¼Ó ¸ð´ÏÅ͸µÀÌ °¡´ÉÇÑ Âü½ÅÇÑ ¿þ¾î·¯ºí µð¹ÙÀ̽º¿Í ¹ÙÀÌ¿À¼¾¼ °³¹ß¿¡ ÀÖ½À´Ï´Ù. °ÈÇÏ°í, º¸´Ù °³º°ÈµÈ Ä¿³ØƼµå ÇコÄÉ¾î ¼Ö·ç¼ÇÀ¸·Î À̾îÁú ¼ö ÀÖ½À´Ï´Ù. ÀÌÇØ°ü°èÀÚ¿¡°Ô´Â °úÁ¦¿Í ±âȸ°¡ ¸ðµÎ ÀÖ½À´Ï´Ù.
½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈÇϴ ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³
ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ ¾ò´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆľÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ À§ÇèÀ» ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ÀÌ´Â Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ´õ¿í ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
- ȯÀÚ ¸ð´ÏÅ͸µ ±â±âÀÇ ±â¼úÀû Áøº¸ ¹× ¹«¼± ¸ð´ÏÅ͸µ ±â±âÀÇ ÀÌ¿ë °¡´É¼º
- ¸¸¼ºÁúȯÀÇ À¯º´·ü »ó½Â
- ÇコÄɾî ÁöºÒÀÚ »çÀÌ¿¡¼ÀÇ ¿þ¾î·¯ºí ȯÀÚ ¸ð´ÏÅ͸µ ±â±â, ¹ÙÀÌ¿À ¼¾¼, ½º¸¶Æ® ÀÓÇöõÆ®¿¡ÀÇ ±âÈ£ÀÇ °íÁ¶
- ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
- ħ½ÀÀû ¸ð´ÏÅ͸µ Àåºñ¿Í °ü·ÃµÈ À§Çè
- ȯÀÚ ¸ð´ÏÅ͸µ Á¦Ç°ÀÇ »ó´ëÀûÀÎ °íºñ¿ë°ú ºÒÃæºÐÇÑ »óȯ±Ý
- ½ÃÀå ±âȸ
- ºñħ½À¼º ¹× Àúħ½À¼º µð¹ÙÀ̽º ½ÃÀåÀÇ ¼ºÀå
- º´¿ø ÀÌ¿ÜÀÇ È¯ÀÚ ¸ð´ÏÅ͸µ ±â±â ¼ö¿ä Áõ°¡
- ½ÃÀåÀÇ °úÁ¦
- ¼÷·Ã ÇコÄɾî Àü¹®°¡ÀÇ ºÎÁ·
- ½ÃÀå ÁøÃâ±â¾÷¿¡ ´ëÇÑ °¡°Ý °æÀïÀÇ °ÝÈ
Portre's Five Forces: ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸
Porter's Five Forces ÇÁ·¹ÀÓ ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ±â¹ýÀ» Á¦°øÇÕ´Ï´Ù. ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¼öÀÖ´Â ´õ °ÀÎÇÑ ½ÃÀå¿¡¼ Æ÷Áö¼Å´×À» º¸Àå ÇÒ ¼ö ÀÖ½À´Ï´Ù.
PESTLE ºÐ¼® : ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå¿¡¼ ¿ÜºÎ ¿µÇâÀ» ÆľÇ
¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÏ¸é ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. À» ¿¹ÃøÇÏ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ°¡µÇ¾î ÀÖ½À´Ï´Ù.
½ÃÀå Á¡À¯À² ºÐ¼® ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå¿¡¼ °æÀï ±¸µµ ÆľÇ
ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. °ø°³ ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ ¹× ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í º¥´õ´Â °æÀïÀÌ Ä¡¿ÇØÁö¸é¼ ÀÚ½ÅÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½Ä ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.
FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå¿¡¼ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡
FPNV Positioning Matrix´Â ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå¿¡¼ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ¿¡ µû¶ó °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀº °ø±Þ¾÷ü¸¦ ¸íÈ®ÇÏ°í Á¤È®ÇÏ°Ô ±¸ºÐÇÏ¿© »ç¿ëÀÚ°¡ Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ½Äº°ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù.
ÀÌ º¸°í¼´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â Á¾ÇÕÀûÀÎ ½ÃÀå ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.
1. ½ÃÀå ħÅõ: ¾÷°è ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅ͸¦ Æ÷ÇÔÇÑ ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä.
2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆľÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.
3. ½ÃÀå ´Ù¾çÈ: ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.
4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.
5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D È°µ¿, Á¦Ç° Çõ½ÅÀ» °Á¶ÇÕ´Ï´Ù.
¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇÏ°í ÀÖ½À´Ï´Ù.
1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?
2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀΰ¡?
3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?
4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?
5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?
¸ñÂ÷
Á¦1Àå ¼¹®
Á¦2Àå Á¶»ç ¹æ¹ý
Á¦3Àå ÁÖ¿ä ¿ä¾à
Á¦4Àå ½ÃÀå °³¿ä
Á¦5Àå ½ÃÀå ÀλçÀÌÆ®
- ½ÃÀå ¿ªÇÐ
- ¼ºÀå ÃËÁø¿äÀÎ
- ȯÀÚ ¸ð´ÏÅ͸µ ±â±âÀÇ ±â¼úÀû Áøº¸¿Í ¹«¼± ¸ð´ÏÅ͸µ ±â±âÀÇ °¡¿ë¼º
- ¸¸¼ºÁúȯÀÇ ¸¸¿¬
- ÇコÄÉ¾î º¸ÇèÀÚ »çÀÌ¿¡¼ ¿þ¾î·¯ºí ȯÀÚ ¸ð´ÏÅ͸µ µð¹ÙÀ̽º, ¹ÙÀÌ¿À ¼¾¼, ½º¸¶Æ® ÀÓÇöõÆ®¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ´Ù
- ¾ïÁ¦¿äÀÎ
- ħ½ÀÀû ¸ð´ÏÅ͸µ ±â±â¿Í °ü·ÃµÈ À§Çè
- ȯÀÚ ¸ð´ÏÅ͸µ Á¦Ç°ÀÇ »ó´ëÀûÀ¸·Î ³ôÀº ºñ¿ë°ú ºÒÃæºÐÇÑ »óȯ
- ±âȸ
- ºñħ½À¼º ¹× Àúħ½À¼º µð¹ÙÀ̽º ½ÃÀå È®´ë
- º´¿ø ÀÌ¿ÜÀÇ È¯°æ¿¡¼ÀÇ È¯ÀÚ ¸ð´ÏÅ͸µ ±â±â ¼ö¿ä Áõ°¡
- °úÁ¦
- ¼÷·ÃµÈ ÇコÄɾî Àü¹®°¡ÀÇ ºÎÁ·
- ½ÃÀå ÁøÃâ±â¾÷¿¡ ´ëÇÑ °¡°Ý ¾Ð·Â Áõ°¡
- ½ÃÀå ¼¼ºÐÈ ºÐ¼®
- Á¦Ç° : Á¤±â °ËÁø ¹× ¼ö¼ú Àü Æò°¡¸¦ À§ÇÑ Â÷¼¼´ë ½ÉÀå ¸ð´ÏÅ͸µ ±â±â¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡,
- ÃÖÁ¾ »ç¿ëÀÚ : ÀçÅà Äɾî ÇöÀå¿¡¼ ÈÞ´ë¿ë ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ¼ö¿ä°¡ Áõ°¡
- Porter's Five Forces ºÐ¼®
- PESTEL ºÐ¼®
- Á¤Ä¡Àû
- °æÁ¦
- »çȸ
- ±â¼úÀû
- ¹ý·ü»ó
- ȯ°æ
Á¦6Àå ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå : Á¦Ç°º°
- Ç÷´ç ¸ð´ÏÅ͸µ ½Ã½ºÅÛ
- Áö¼Ó Ç÷´ç ¸ð´ÏÅ͸µ ½Ã½ºÅÛ
- ÀÚ±â Ç÷´ç ÃøÁ¤ ½Ã½ºÅÛ
- ½ÉÀå ¸ð´ÏÅ͸µ ±â±â
- ECG µð¹ÙÀ̽º
- À̺¥Æ® ¸ð´ÏÅÍ
- À̽ÄÇü ·çÇÁ ·¹ÄÚ´õ
- ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ¸ð´ÏÅÍ
- ½º¸¶Æ®/¿þ¾î·¯ºí ECG ¸ð´ÏÅÍ
- ÅÂ¾Æ ¹× ½Å»ý¾Æ ¸ð´ÏÅ͸µ ±â±â
- ÅÂ¾Æ ¸ð´ÏÅ͸µ ±â±â
- ½Å»ý¾Æ ¸ð´ÏÅ͸µ ±â±â
- Ç÷ÇൿÅÂ/¾Ð·Â ¸ð´ÏÅ͸µ ±â±â
- Ç÷¾Ð ¸ð´ÏÅÍ
- ÀÏȸ¿ë
- Ç÷ÇൿÅ ¸ð´ÏÅÍ
- ¸ÖƼÆĶó¹ÌÅÍ ¸ð´ÏÅ͸µ µð¹ÙÀ̽º
- °íÁ¤¹Ð ¸ð´ÏÅ͸µ ±â±â
- Àú°¨µµ ¸ð´ÏÅ͸µ ±â±â
- Áߵ ¸ð´ÏÅ͸µ ±â±â
- ½Å°æ ¸ð´ÏÅ͸µ ±â±â
- ³ú»ê¼Ò Æ÷ȵµ°è
- ³úÆÄ°è
- ±ÙÀüµµ °Ë»ç Àåºñ
- µÎ°³ ³»¾Ð ¸ð´ÏÅÍ
- ³úÀÚµµ ±â°è
- °æµÎ°³ µµÇ÷¯ Àåºñ
- È£Èí ¸ð´ÏÅ͸µ ±â±â
- Ä«ÇÁ³ë±×·¡ÇÁ
- ÇÇÅ© À¯·®°è
- »ê¼ÒÆ÷ȵµ ÃøÁ¤±â
- ½ºÆÄÀ̷ιÌÅÍ
- ¿Âµµ ¸ð´ÏÅ͸µ ±â±â
- ÇÚµåÇïµå ¿Âµµ ¸ð´ÏÅ͸µ ±â±â
- ħ½À¼º ¿Âµµ ¸ð´ÏÅ͸µ ±â±â
- ½º¸¶Æ® ¿Âµµ ¸ð´ÏÅ͸µ ±â±â
- Ź»ó ¿Âµµ ¸ð´ÏÅ͸µ ±â±â
- ¿þ¾î·¯ºí ¿¬¼Ó ¸ð´ÏÅ͸µ ±â±â
- üÁß ¸ð´ÏÅ͸µ ±â±â
Á¦7Àå ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°
- ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
- °¡Á¤Ä¡·á ȯ°æ
- º´¿ø
Á¦8Àå ¾Æ¸Þ¸®Ä« ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå
- ¾Æ¸£ÇîƼ³ª
- ºê¶óÁú
- ij³ª´Ù
- ¸ß½ÃÄÚ
- ¹Ì±¹
Á¦9Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ È¯ÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå
- È£ÁÖ
- Áß±¹
- Àεµ
- Àεµ³×½Ã¾Æ
- ÀϺ»
- ¸»·¹À̽þÆ
- Çʸ®ÇÉ
- ½Ì°¡Æ÷¸£
- Çѱ¹
- ´ë¸¸
- ű¹
- º£Æ®³²
Á¦10Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå
- µ§¸¶Å©
- ÀÌÁýÆ®
- Çɶõµå
- ÇÁ¶û½º
- µ¶ÀÏ
- À̽º¶ó¿¤
- ÀÌÅ»¸®¾Æ
- ³×´ú¶õµå
- ³ªÀÌÁö¸®¾Æ
- ³ë¸£¿þÀÌ
- Æú¶õµå
- īŸ¸£
- ·¯½Ã¾Æ
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ³²¾ÆÇÁ¸®Ä«
- ½ºÆäÀÎ
- ½º¿þµ§
- ½ºÀ§½º
- ÅÍÅ°
- ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
- ¿µ±¹
Á¦11Àå °æÀï ±¸µµ
- ½ÃÀå Á¡À¯À² ºÐ¼® 2023
- FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
- °æÀï ½Ã³ª¸®¿À ºÐ¼®
- Pylo Health, Â÷¼¼´ë ¼¿·ê·¯ Á¢¼Ó ¸®¸ðÄÁÀ» ¹ß¸Å ȯÀÚ ¸ð´ÏÅ͸µ ±â±â
- Philips°¡ ºñÁÖ¾ó ȯÀÚ ¾Æ¹ÙŸ ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀ» ¹ßÇ¥
- ±×·¹ÀÎÀú Çコ, ÀÇ·á±â±â ¹× µ¥ÀÌÅÍ ºÐ¼® ȸ»çÀÇ Àμö¸¦ ¹ßÇ¥
±â¾÷ ¸ñ·Ï
- Natus Medical Incorporated
- Koninklijke Philips NV
- Abbott Laboratories
- Boston Scientific Corporation
- Schiller AG
- Omron Corporation
- Cardiomo Care Inc. by Delaware corporation
- Dexcom, Inc.
- Medtronic PLC
- Masimo Corporation
- Hill-Rom Holdings, Inc. by Baxter International Inc.
- AliveCor, Inc.
- Fisher & Paykel Healthcare Corporation Limited
- Edwards Lifesciences Corporation
- Nonin Medical, Inc.
- Stryker Corporation
- Nihon Kohden Corporation
- BIOTRONIK SE & Co KG
- Dragerwerk AG & Co. KGaA
- Compumedics Limited
- Mindray Medical International Limited
- Getinge AB
- 100 Plus by ConnectAmerica.com, LLC
- Pylo Health
- GE HealthCare Technologies Inc.
- ChroniSense Medical, Ltd.
KSA
The Patient Monitoring Devices Market was valued at USD 51.24 billion in 2023, expected to reach USD 57.96 billion in 2024, and is projected to grow at a CAGR of 13.30%, to USD 122.89 billion by 2030.
The scope of patient monitoring devices encompasses tools and technologies employed in tracking vital health parameters such as heart rate, blood pressure, oxygen saturation, and respiratory rate in various healthcare settings, including hospitals, clinics, and even homes. These devices are crucial for continuous health monitoring, timely medical interventions, and improving patient outcomes in chronic disease management, post-operative care, and critical care scenarios. Key end-use sectors involve individual patients, hospitals, ambulatory care centers, and home-based care, highlighting their versatile applications across different healthcare environments. Market growth is significantly influenced by the burgeoning aging population, rising prevalence of chronic diseases, and rapid technological advancements like AI integration and wearable technology. Furthermore, the increasing demand for remote and wireless monitoring solutions during and post-COVID-19 emphasizes the potential for telehealth expansion, offering a substantial growth opportunity.
KEY MARKET STATISTICS |
Base Year [2023] |
USD 51.24 billion |
Estimated Year [2024] |
USD 57.96 billion |
Forecast Year [2030] |
USD 122.89 billion |
CAGR (%) |
13.30% |
To capitalize on this potential, it is advisable for healthcare solutions providers to invest in AI-powered remote monitoring technologies, enhancing data accuracy and enabling predictive analytics for proactive patient care. Innovations focusing on interoperability and integration with existing EMR systems could also unlock new opportunities. However, market growth faces limitations due to high initial costs, regulatory hurdles, and concerns over data security and patient privacy. Overcoming these barriers is essential for broader market adoption. Additionally, ongoing research in sensor technology and non-invasive monitoring could lead to significant advancements.
Challenges notwithstanding, the market's innovative frontier lies in developing novel wearable devices and biosensors that are user-friendly and offer real-time, continuous monitoring. Partnerships between tech companies and healthcare providers could further enhance R&D initiatives, leading to more personalized and connected healthcare solutions. The market is dynamic, with a shifting focus toward patient-centric care models, which presents both challenges and opportunities for stakeholders aiming to establish a strong foothold in this evolving landscape.
Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Patient Monitoring Devices Market
The Patient Monitoring Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.
- Market Drivers
- Technological Advancement in Patient Monitoring Devices & Availability of Wireless Monitoring Devices
- Rising Prevalence of Chronic Diseases
- Increasing Preference for Wearable Patient Monitoring Devices, Biosensors, and Smart Implants among Healthcare Payers
- Market Restraints
- Risks Associated with Invasive Monitoring Devices
- Relative High Cost of Patient Monitoring Products and Inadequate Reimbursement
- Market Opportunities
- Growing Market for Non-Invasive and Minimally Invasive Devices
- Increasing Demand for Patient Monitoring Devices in Non-Hospital Settings
- Market Challenges
- Lack of Skilled Healthcare Professionals
- Increasing Pricing Pressure on Market Players
Porter's Five Forces: A Strategic Tool for Navigating the Patient Monitoring Devices Market
Porter's five forces framework is a critical tool for understanding the competitive landscape of the Patient Monitoring Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.
PESTLE Analysis: Navigating External Influences in the Patient Monitoring Devices Market
External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Patient Monitoring Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.
Market Share Analysis: Understanding the Competitive Landscape in the Patient Monitoring Devices Market
A detailed market share analysis in the Patient Monitoring Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.
FPNV Positioning Matrix: Evaluating Vendors' Performance in the Patient Monitoring Devices Market
The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Patient Monitoring Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.
Key Company Profiles
The report delves into recent significant developments in the Patient Monitoring Devices Market, highlighting leading vendors and their innovative profiles. These include Natus Medical Incorporated, Koninklijke Philips N.V., Abbott Laboratories, Boston Scientific Corporation, Schiller AG, Omron Corporation, Cardiomo Care Inc. by Delaware corporation, Dexcom, Inc., Medtronic PLC, Masimo Corporation, Hill-Rom Holdings, Inc. by Baxter International Inc., AliveCor, Inc., Fisher & Paykel Healthcare Corporation Limited, Edwards Lifesciences Corporation, Nonin Medical, Inc., Stryker Corporation, Nihon Kohden Corporation, BIOTRONIK SE & Co KG, Dragerwerk AG & Co. KGaA, Compumedics Limited, Mindray Medical International Limited, Getinge AB, 100 Plus by ConnectAmerica.com, LLC, Pylo Health, GE HealthCare Technologies Inc., and ChroniSense Medical, Ltd..
Market Segmentation & Coverage
This research report categorizes the Patient Monitoring Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Based on Product, market is studied across Blood Glucose Monitoring Systems, Cardiac Monitoring Devices, Fetal & Neonatal Monitoring Devices, Hemodynamic/Pressure Monitoring Devices, Multi-parameter Monitoring Devices, Neuromonitoring Devices, Respiratory Monitoring Devices, Temperature Monitoring Devices, and Weight Monitoring Devices. The Blood Glucose Monitoring Systems is further studied across Continuous Glucose Monitoring Systems and Self-monitoring Blood Glucose Systems. The Cardiac Monitoring Devices is further studied across ECG Devices, Event Monitors, Implantable Loop Recorders, Mobile Cardiac Telemetry Monitors, and Smart/Wearable ECG Monitors. The Fetal & Neonatal Monitoring Devices is further studied across Fetal Monitoring Devices and Neonatal Monitoring Devices. The Hemodynamic/Pressure Monitoring Devices is further studied across Blood Pressure Monitors, Disposables, and Hemodynamic Monitors. The Multi-parameter Monitoring Devices is further studied across High-acuity Monitoring Devices, Low-acuity Monitoring Devices, and Mid-acuity Monitoring Devices. The Neuromonitoring Devices is further studied across Cerebral Oximeters, Electroencephalograph Machines, Electromyography Machines, Intracranial Pressure Monitors, Magnetoencephalography Machines, and Transcranial Doppler Machines. The Respiratory Monitoring Devices is further studied across Capnographs, Peak Flow Meters, Pulse Oximeters, and Spirometers. The Temperature Monitoring Devices is further studied across Handheld Temperature Monitoring Devices, Invasive Temperature Monitoring Devices, Smart Temperature Monitoring Devices, Table-top Temperature Monitoring Devices, and Wearable Continuous Monitoring Devices. The Weight Monitoring Devices is further studied across Analog and Digital.
- Based on End User, market is studied across Ambulatory Surgery Centers, Home Care Settings, and Hospitals.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
The report offers a comprehensive analysis of the market, covering key focus areas:
1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.
2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.
3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.
4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.
5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.
The report also answers critical questions to aid stakeholders in making informed decisions:
1. What is the current market size, and what is the forecasted growth?
2. Which products, segments, and regions offer the best investment opportunities?
3. What are the key technology trends and regulatory influences shaping the market?
4. How do leading vendors rank in terms of market share and competitive positioning?
5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Technological Advancement in Patient Monitoring Devices & Availability of Wireless Monitoring Devices
- 5.1.1.2. Rising Prevalence of Chronic Diseases
- 5.1.1.3. Increasing Preference for Wearable Patient Monitoring Devices, Biosensors, and Smart Implants among Healthcare Payers
- 5.1.2. Restraints
- 5.1.2.1. Risks Associated with Invasive Monitoring Devices
- 5.1.2.2. Relative High Cost of Patient Monitoring Products and Inadequate Reimbursement
- 5.1.3. Opportunities
- 5.1.3.1. Growing Market for Non-Invasive and Minimally Invasive Devices
- 5.1.3.2. Increasing Demand for Patient Monitoring Devices in Non-Hospital Settings
- 5.1.4. Challenges
- 5.1.4.1. Lack of Skilled Healthcare Professionals
- 5.1.4.2. Increasing Pricing Pressure on Market Players
- 5.2. Market Segmentation Analysis
- 5.2.1. Product: Rising investment across next generation cardiac monitoring devices for routine check-ups and pre-surgical assessments,
- 5.2.2. End User: Rising demand for portable patient monitoring devices across home care settings
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
- 5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental
- 5.5. Client Customization
6. Patient Monitoring Devices Market, by Product
- 6.1. Introduction
- 6.2. Blood Glucose Monitoring Systems
- 6.2.1. Continuous Glucose Monitoring Systems
- 6.2.2. Self-monitoring Blood Glucose Systems
- 6.3. Cardiac Monitoring Devices
- 6.3.1. ECG Devices
- 6.3.2. Event Monitors
- 6.3.3. Implantable Loop Recorders
- 6.3.4. Mobile Cardiac Telemetry Monitors
- 6.3.5. Smart/Wearable ECG Monitors
- 6.4. Fetal & Neonatal Monitoring Devices
- 6.4.1. Fetal Monitoring Devices
- 6.4.2. Neonatal Monitoring Devices
- 6.5. Hemodynamic/Pressure Monitoring Devices
- 6.5.1. Blood Pressure Monitors
- 6.5.2. Disposables
- 6.5.3. Hemodynamic Monitors
- 6.6. Multi-parameter Monitoring Devices
- 6.6.1. High-acuity Monitoring Devices
- 6.6.2. Low-acuity Monitoring Devices
- 6.6.3. Mid-acuity Monitoring Devices
- 6.7. Neuromonitoring Devices
- 6.7.1. Cerebral Oximeters
- 6.7.2. Electroencephalograph Machines
- 6.7.3. Electromyography Machines
- 6.7.4. Intracranial Pressure Monitors
- 6.7.5. Magnetoencephalography Machines
- 6.7.6. Transcranial Doppler Machines
- 6.8. Respiratory Monitoring Devices
- 6.8.1. Capnographs
- 6.8.2. Peak Flow Meters
- 6.8.3. Pulse Oximeters
- 6.8.4. Spirometers
- 6.9. Temperature Monitoring Devices
- 6.9.1. Handheld Temperature Monitoring Devices
- 6.9.2. Invasive Temperature Monitoring Devices
- 6.9.3. Smart Temperature Monitoring Devices
- 6.9.4. Table-top Temperature Monitoring Devices
- 6.9.5. Wearable Continuous Monitoring Devices
- 6.10. Weight Monitoring Devices
- 6.10.1. Analog
- 6.10.2. Digital
7. Patient Monitoring Devices Market, by End User
- 7.1. Introduction
- 7.2. Ambulatory Surgery Centers
- 7.3. Home Care Settings
- 7.4. Hospitals
8. Americas Patient Monitoring Devices Market
- 8.1. Introduction
- 8.2. Argentina
- 8.3. Brazil
- 8.4. Canada
- 8.5. Mexico
- 8.6. United States
9. Asia-Pacific Patient Monitoring Devices Market
- 9.1. Introduction
- 9.2. Australia
- 9.3. China
- 9.4. India
- 9.5. Indonesia
- 9.6. Japan
- 9.7. Malaysia
- 9.8. Philippines
- 9.9. Singapore
- 9.10. South Korea
- 9.11. Taiwan
- 9.12. Thailand
- 9.13. Vietnam
10. Europe, Middle East & Africa Patient Monitoring Devices Market
- 10.1. Introduction
- 10.2. Denmark
- 10.3. Egypt
- 10.4. Finland
- 10.5. France
- 10.6. Germany
- 10.7. Israel
- 10.8. Italy
- 10.9. Netherlands
- 10.10. Nigeria
- 10.11. Norway
- 10.12. Poland
- 10.13. Qatar
- 10.14. Russia
- 10.15. Saudi Arabia
- 10.16. South Africa
- 10.17. Spain
- 10.18. Sweden
- 10.19. Switzerland
- 10.20. Turkey
- 10.21. United Arab Emirates
- 10.22. United Kingdom
11. Competitive Landscape
- 11.1. Market Share Analysis, 2023
- 11.2. FPNV Positioning Matrix, 2023
- 11.3. Competitive Scenario Analysis
- 11.3.1. Pylo Health Launches Next Generation of Cellular-Connected Remote Patient Monitoring Devices
- 11.3.2. Philips launches Visual Patient Avatar monitoring solution
- 11.3.3. Granger Health Announces Acquisition of Medical Device and Data Analytics Company
Companies Mentioned
- 1. Natus Medical Incorporated
- 2. Koninklijke Philips N.V.
- 3. Abbott Laboratories
- 4. Boston Scientific Corporation
- 5. Schiller AG
- 6. Omron Corporation
- 7. Cardiomo Care Inc. by Delaware corporation
- 8. Dexcom, Inc.
- 9. Medtronic PLC
- 10. Masimo Corporation
- 11. Hill-Rom Holdings, Inc. by Baxter International Inc.
- 12. AliveCor, Inc.
- 13. Fisher & Paykel Healthcare Corporation Limited
- 14. Edwards Lifesciences Corporation
- 15. Nonin Medical, Inc.
- 16. Stryker Corporation
- 17. Nihon Kohden Corporation
- 18. BIOTRONIK SE & Co KG
- 19. Dragerwerk AG & Co. KGaA
- 20. Compumedics Limited
- 21. Mindray Medical International Limited
- 22. Getinge AB
- 23. 100 Plus by ConnectAmerica.com, LLC
- 24. Pylo Health
- 25. GE HealthCare Technologies Inc.
- 26. ChroniSense Medical, Ltd.